DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Zanubrutinib 80 MG ( DrugBank:
Zanubrutinib
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
300
IgG4関連疾患
1
300. IgG4関連疾患
臨床試験数
:
40
/
薬物数
:
47
- (
DrugBank
:
21
) /
標的遺伝子数
:
18
-
標的パスウェイ数
:
141
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT04602598
(
ClinicalTrials.gov
)
August 1, 2022
20/10/2020
Zanubrutinib in Patients With IgG4-Related Disease
A Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients With IgG4-Related Disease
IgG4 Related Disease
Drug:
Zanubrutinib 80 MG
Matthew C. Baker
Stanford University
Recruiting
18 Years
85 Years
All
10
Phase 2
United States